Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**Repavar Atopic Piel** is a line of emollient skincare products formulated for atopic skin, particularly during flare-ups and for daily maintenance. It contains **Skincalm Complex**, a blend of active ingredients including linoleic acid, hydrolyzed vegetable protein, biomimetic lipid complex (ceramides NP, AP, EOP, cholesterol, phytosphingosine), seven plant extracts (Centella asiatica, Polygonum cuspidatum, Scutellaria baicalensis, Camellia sinensis, Chamomilla recutita, Glycyrrhiza glabra, Rosmarinus officinalis, Peumus boldus), dihidroavenantramida D, and boldo extract, which provide antihistaminic, anti-irritant, anti-inflammatory, antipruritic, and antioxidant effects. The products restore the skin's hydrolipidic barrier, reduce transepidermal water loss, promote epidermal protein synthesis, offer antimicrobial protection, and alleviate itching, redness, and extreme dryness more effectively than corticosteroids in vitro for preventing pro-inflammatory molecule release. Dermatologically and pediatrically tested, hypoallergenic, suitable for sensitive skin and children over 1 month, available as cream (extreme and facial), lotion, bath gel, shampoo, and oleoducha.[1][2][4][7]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Repavar Atopic Piel.